Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma
Jesper Pedersen(Aarhus University), Martin R. Jakobsen(Aarhus University), Ninna Aggerholm‐Pedersen(Aarhus University Hospital), Mateo Sokač(Aarhus University), Nicolai J. Birkbak(Brigham and Women's Hospital), A.A. Luczak(Aalborg University Hospital), Trine Heide Øllegaard(Aarhus University Hospital), Boe Sandahl Sørensen(Aarhus University Hospital)
Cited by 22
Related Papers
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
|Cancer Discovery|2012|684